Meet Dr. James “’Jim” Porter, a board-certified Clinical Neuropsychologist who has been serving the Minnesota community since 2015.
Jim’s clinical interests span a wide spectrum, focusing on adult patients grappling with neurological conditions that impact cognition and behavior.
His expertise covers a range of disorders, including dementia syndromes like Alzheimer’s and Lewy body disease, movement disorders such as Parkinson’s disease, strokes and cerebrovascular diseases, multiple sclerosis, brain injuries, seizure disorders, and more.
Notably, Jim has developed a subspecialty in diagnosing dementia in individuals with Down syndrome, addressing lifelong cognitive concerns with nuanced understanding and care.
At the heart of Jim’s patient care philosophy is a commitment to demystifying cognitive and behavioral challenges. He dedicates himself to not only identifying the root causes of these difficulties but also uncovering treatment possibilities and lifestyle adjustments that can enhance his patients’ quality of life.
Jim’s approach is patient-centered, emphasizing the importance of understanding and support in navigating the complexities of neurological conditions.
I’m very glad Dr. Veen was easy to talk to, seemed very in tuned with what I was saying (an active listener), and didn’t bowl me over with why I was wrong or why she knew so much more (which she does) than me. She let me share my anxiety and then set about describing how “we” were going to tackle diagnosing and treating whatever we found. That was encouraging to me even though some of the discussion was very much anxiety generating. Dr. Veen answered all of our questions and was so comfortable talking to her. She really listened to what we had to say. This was my first time doing a telemedicine appointment and it was very easy and the doctor was as complete as could be without physical interaction. Because of Covid, we had to make appt for a phone visit. We were a little skeptical of this but everything went good. All questions were addressed and a follow up was discussed. Dr. Veen as always gets an A+. I was particularly impressed that the providers came to the waiting room for their patients and escorted them to their offices. Dr Veen gets max points for listening to everything I had to say, seeking my input and developing a mutual plan for next steps. Kudos! Dr. Veen is excellent. I do recommender her to friends!!
Whiteside, D., Basso, M., Shen, C., Fry, L., Naini, S., Waldron, E., Holker, E., Porter, J., Eskridge, C., Logemann, A., & Minor, G. (2024). The relationship between performance validity testing, external incentives, and cognitive functioning in Long COVID. The Journal of Clinical and Experimental Neuropsychology, Feb 1:1-10, online ahead of print.
Fry, L., Logemann, A., Waldron, E., Holker, E., Porter, J., Eskridge, C., Naini, S., Basso, M. R., Taylor, S.E., Melnik, T., Whiteside, D. M. (2023). Emotional functioning in long COVID neuropsychological evaluations: Comparison to post-concussion Syndrome using the Personality Assessment Inventory. The Clinical Neuropsychologist, Oct 15:1-21, online ahead of print.
Whiteside, D., Basso, M., Naini, S., Porter, J., Holker, E., Waldron, E., Melnik, T., Niskanen, N., & Taylor, S. (2022). Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning. The Clinical Neuropsychologist, 36(4), 806-828.
Whiteside, D., Naini, S., Basso, M., Waldron, E., Holker, E., Porter, J., Niskanen, N., Melnik, T., & Taylor, S. (2022). Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection part 2: Psychological functioning. The Clinical Neuropsychologist, 36(4), 829-847.
Wisner, K., Johnson, M., Porter, J., Krueger, R., & MacDonald, A. (2021). Task-related neural mechanisms of persecutory ideation in schizophrenia and community monozygotic twin-pairs. Human Brain Mapping, 2021 Nov;42(16):5244-5263
Whiteside, D., Oleynick, V., Holker, E., Waldron, E., Porter, J., & Kasprzak, M. (2020). Neurocognitive deficits in severe COVID-19 infection: Case series and proposed model. The Clinical Neuropsychologist, 35(4), 799-818.
Hinkle, C., Porter, J., Waldron, E., Klein, H., Tranel, D., & Heffelfinger, A. (2016). Neuropsychological characterization of three adolescent females with anti-NMDA receptor encephalitis in the acute, post- acute, and chronic phases: An inter-institutional case series. The Clinical Neuropsychologist, 31: 268-288.
Porter, J., Roy, A., Benson, B., Carlisi, C., Collins, P., Leibenluft, E., Pine, D., Luciana, M., & Ernst, M. (2015). Age-related changes in the intrinsic functional connectivity of the human ventral vs. dorsal striatum from childhood to middle age. Developmental Cognitive Neuroscience, 11: 83–95.
Menary, K., Collins, P, Porter, J., Muetzel, R., Olson, E., Kumar, V., Steinbach, M., Lim, K., & Luciana, M. (2013). Associations between cortical thickness and general intelligence in children, adolescents and young adults. Intelligence, 41: 597–606.
Luciana, M., Wahlstrom, D., Porter, J., & Collins, P. (2012). Dopaminergic modulation of incentive motivation in adolescence: Age-related changes in signaling, individual differences, and implications for the development of self-regulation. Developmental Psychology, 48(3): 844–861.
Porter, J., Collins, P., Muetzel, R., Lim, K., & Luciana, M. (2011). Associations between cortical thickness and verbal fluency in childhood, adolescence, and young adulthood. NeuroImage, 55(4): 1865– 1877.